Exact Mass: 523.137204

Exact Mass Matches: 523.137204

Found 7 metabolites which its exact mass value is equals to given mass value 523.137204, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Deoxyribonucleic acid

[(5-amino-2-{[({[5-amino-2-(hydroxymethyl)oxolan-3-yl]oxy}(hydroxy)phosphoryl)oxy]methyl}oxolan-3-yl)oxy][(5-amino-3-hydroxyoxolan-2-yl)methoxy]phosphinic acid

C15H31N3O13P2 (523.1332056)


   

Hapten

3-(3-chloro-4-{14-cyclopropanecarbonyl-3,7-dimethyl-17-thia-2,4,5,8,14-pentaazatetracyclo[8.7.0.0^{2,6}.0^{11,16}]heptadeca-1(10),3,5,8,11(16)-pentaen-9-yl}phenyl)propanoic acid

C26H26ClN5O3S (523.1444796000001)


   

Fmoc-Cys(Xan)-OH

Fmoc-Cys(Xan)-OH

C31H25NO5S (523.145336)


   

Idoxifene

Idoxifene

C28H30INO (523.137204)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D004965 - Estrogen Antagonists C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C1821 - Selective Estrogen Receptor Modulator C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent > C481 - Antiestrogen C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C483 - Therapeutic Estrogen C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist C1892 - Chemopreventive Agent

   

Hapten

Hapten

C26H26ClN5O3S (523.1444796000001)


   

N-[3-[3-(1-piperidinylsulfonyl)anilino]-2-quinoxalinyl]benzenesulfonamide

N-[3-[3-(1-piperidinylsulfonyl)anilino]-2-quinoxalinyl]benzenesulfonamide

C25H25N5O4S2 (523.1347890000001)


   

Ninerafaxstat (trihydrochloride)

Ninerafaxstat (trihydrochloride)

C22H32Cl3N3O5 (523.1407432)


Ninerafaxstat (IMB-1018972) trihydrochloride is a novel mitotropic agent. Ninerafaxstat trihydrochloride increases myocardial metabolic efficiency by shifting substrate utilization towards glucose through reducing fatty acid oxidation (inhibiting 3-ketoacyl CoA thiolase). Ninerafaxstat trihydrochloride can be used for the research of cardiovascular diseases[1].